elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26993238-50BC6F0B-6712-4245-8B35-A0539A6691F8
Q26993238-50BC6F0B-6712-4245-8B35-A0539A6691F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-50BC6F0B-6712-4245-8B35-A0539A6691F8
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
P2860
Q26993238-50BC6F0B-6712-4245-8B35-A0539A6691F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-50BC6F0B-6712-4245-8B35-A0539A6691F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0bd763788559a2ce9fc7aa0fd30997f744c53bbc
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer